Cargando…
A New Index Based on Serum Creatinine and Cystatin C Can Predict the Risks of Sarcopenia, Falls and Fractures in Old Patients with Low Bone Mineral Density
As new screening tools for sarcopenia, the serum sarcopenia index (SI) and creatinine/cystatin C ratio (CCR) had not been confirmd in a population with a high fragility fracture risk. This study aimed to evaluate whether SI and CCR indicators are useful for diagnosing sarcopenia and to determine the...
Autores principales: | Ge, Jiaying, Zeng, Jiangping, Ma, Huihui, Sun, Siqi, Zhao, Zheng, Jing, Yujie, Qian, Chunhua, Fei, Zhaoliang, Cui, Ran, Qu, Shen, Zhang, Ge, Sheng, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738634/ https://www.ncbi.nlm.nih.gov/pubmed/36501049 http://dx.doi.org/10.3390/nu14235020 |
Ejemplares similares
-
Soluble interleukin 2 receptor is risk for sarcopenia in Men with high fracture risk
por: Ge, Jiaying, et al.
Publicado: (2022) -
Sarcopenia Index Based on Serum Creatinine and Cystatin C is Associated with Mortality, Nutritional Risk/Malnutrition and Sarcopenia in Older Patients
por: Ren, Chenxi, et al.
Publicado: (2022) -
Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer
por: Zheng, Chao, et al.
Publicado: (2022) -
A Novel Application of Serum Creatinine and Cystatin C to Predict Sarcopenia in Advanced CKD
por: Lin, Yu-Li, et al.
Publicado: (2022) -
Sarcopenia index based on serum creatinine and cystatin C is associated with 3-year mortality in hospitalized older patients
por: Tang, Tianjiao, et al.
Publicado: (2020)